Automated Immunoassay Analyzers Market Will Retain 15% Cagr To Cross $25 Billion By 2024
Automated Immunoassay Analyzers Market Will Retain 15% Cagr To Cross $25 Billion By 2024
Automated Immunoassay Analyzers Market Size By Product, By Application, By End-use & Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 - 2024
SELLBYVILLE, Del., March 21, 2018 /PRNewswire-iReach/ -- Global Automated Immunoassay Analyzers Market is poised to exceed USD 25 billion by 2024; according to a new research study published by Global Market Insights, Inc. Rising prevalence of infectious diseases and growing geriatric population has led to high diagnostic test volumes, aiding a trend shift towards lab automation. Technological innovation for development of effective lab equipment will drive global automated immunoassay analyzers market.
Increasing consolidation in laboratories and hospitals in the wake of health care reform to curb healthcare expenses should stimulate the industry growth. Rising number of centralized laboratories and large reference labs should escalate the demand for automated immunoassay analyzer systems.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1727
Adoption of innovative diagnostic technologies should lead to prolific growth in automated immunoassay analyzers market. New product launches with ability to perform more than one test at a time using software allows diagnostic laboratories to perform routine as well as specialized tests.
Stringent regulatory framework and need to operate under rising pricing pressures adversely impacts the profit margins for the laboratories inhibiting the business growth. Laboratories are focusing on high volume testing to improve profitability per test and adopt automated systems to provide accurate diagnosis with effective workflow solutions.
Browse key industry insights spread across 150 pages with 90 market data tables & 11 figures & charts from the report, "Automated Immunoassay Analyzers Market" in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/automated-immunoassay-analyzers-market
Chemiluminescence analyzers should witness robust growth owing to the sensitivity and accuracy of diagnosis using low analyte concentrations. The automated chemiluminescent immunoassay analyzers improve the work efficiency by identifying over hundreds of analytes per hour.
Infectious diseases should witness a healthy growth to surpass USD 7 billion by 2024. Rising incidence of infectious diseases, growing elderly population and improved healthcare systems is set to drive segment growth.
U.S. automated immunoassay analyzers market accounted for more than 90% of regional industry revenue in 2016. Favorable healthcare reforms for diagnostic care, adoption of innovative products and increasing consolidation of laboratories should boost demand for automated instruments used for high volume testing.
India should witness robust regional growth over forecast years owing to increasing government focus towards development of healthcare infrastructure by encouraging public private partnership to improve healthcare delivery into rural markets. Furthermore, increasing number of pathology laboratories and rising number of private and public hospitals should fuel automated immunoassay analyzers market growth.
Some of the prominent industry players in the competitive market include Abbott Diagnostics, Biokit, Carolina Liquid Chemistries Corporation, Luminex Corporation, Ortho Clinical Diagnostics, Roche Diagnostics, and Siemens Healthcare.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1727
The automated immunoassay analyzers market is dominated by few companies with a strong financial muscle, expanded geographical footprint, and extensive product portfolio. New product launch or customizing existing product by adding broad assay of test menus is the major trend adopted by industry participants to hold their market position.
Browse Related Reports:
Breast Cancer Therapeutics Market Size 2017 - 2024
Breast Cancer Therapeutics Market share was valued over USD 13 billion in 2016 and is expected to witness more than 9% CAGR from 2017 to 2024. Rising prevalence of breast cancer pertaining to factors like prolonged exposure to endogenous estrogens, early menarche, late age at first childbirth and late menopause will be a high impact rendering factor for the industry growth.
https://www.gminsights.com/industry-analysis/breast-cancer-therapeutics-market
Cancer Diagnostics Market Size 2017 - 2024
Cancer Diagnostics Market share was valued over USD 84.1 billion in 2016 and is expected to witness more than 8.1% CAGR from 2017 to 2024. Rising incidences of cancer along with growing awareness about early disease diagnosis and prevention will drive the market over the forecast timeframe.
https://www.gminsights.com/industry-analysis/cancer-diagnostics-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://www.gminsights.com/blogs
Media Contact: Arun Hegde, Global Market Insights, Inc., +13028467766, sales@gminsights.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Market Insights, Inc.
